390 related articles for article (PubMed ID: 33453282)
1. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
[TBL] [Abstract][Full Text] [Related]
2. Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer's Disease.
Hosseinpour Mashkani SM; Bishop DP; Raoufi-Rad N; Adlard PA; Shimoni O; Golzan SM
Cells; 2023 Apr; 12(8):. PubMed ID: 37190053
[TBL] [Abstract][Full Text] [Related]
3. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.
Ciavardelli D; Silvestri E; Del Viscovo A; Bomba M; De Gregorio D; Moreno M; Di Ilio C; Goglia F; Canzoniero LM; Sensi SL
Cell Death Dis; 2010 Oct; 1(10):e90. PubMed ID: 21368863
[TBL] [Abstract][Full Text] [Related]
4. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
6. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
[TBL] [Abstract][Full Text] [Related]
8. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
10. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
11. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
13. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
14. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
15. High-precision isotopic analysis of serum and whole blood Cu, Fe and Zn to assess possible homeostasis alterations due to bariatric surgery.
Hastuti AAMB; Costas-Rodríguez M; Anoshkina Y; Parnall T; Madura JA; Vanhaecke F
Anal Bioanal Chem; 2020 Jan; 412(3):727-738. PubMed ID: 31836925
[TBL] [Abstract][Full Text] [Related]
16. High Dietary Iron Disrupts Iron Homeostasis and Induces Amyloid-β and Phospho-τ Expression in the Hippocampus of Adult Wild-Type and APP/PS1 Transgenic Mice.
Chen M; Zheng J; Liu G; Zeng C; Xu E; Zhu W; Anderson GJ; Chen H
J Nutr; 2019 Dec; 149(12):2247-2254. PubMed ID: 31373375
[TBL] [Abstract][Full Text] [Related]
17. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
[TBL] [Abstract][Full Text] [Related]
18. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.
Héraud C; Goufak D; Ando K; Leroy K; Suain V; Yilmaz Z; De Decker R; Authelet M; Laporte V; Octave JN; Brion JP
Neurobiol Dis; 2014 Feb; 62():100-12. PubMed ID: 24076100
[TBL] [Abstract][Full Text] [Related]
19. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]